<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD with OASIS Tables v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing-oasis-article1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Microbes Infect</journal-id><journal-id journal-id-type="iso-abbrev">Emerg Microbes Infect</journal-id><journal-id journal-id-type="publisher-id">TEMI</journal-id><journal-id journal-id-type="publisher-id">temi20</journal-id><journal-title-group><journal-title>Emerging Microbes &#x00026; Infections</journal-title></journal-title-group><issn pub-type="epub">2222-1751</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32196430</article-id><article-id pub-id-type="publisher-id">1745095</article-id><article-id pub-id-type="doi">10.1080/22221751.2020.1745095</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Laboratory diagnosis of emerging human coronavirus infections &#x02013; the state of
the art</article-title><alt-title alt-title-type="running-title">Emerging Microbes &#x00026; Infections</alt-title><alt-title alt-title-type="running-authors">M. J. Loeffelholz and Y.-W. Tang</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Loeffelholz</surname><given-names>Michael J.</given-names></name><xref ref-type="aff" rid="AF1">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Yi-Wei</given-names></name><xref ref-type="aff" rid="AF2">
<sup>b</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>CONTACT</sup>
</xref></contrib><aff id="AF1"><label>a</label><institution>Cepheid</institution>, Sunnyvale, CA,
<country>USA</country></aff><aff id="AF2"><label>b</label><institution>Cepheid, Danaher Diagnostic
Platform</institution>, Shanghai, <country>People&#x02019;s Republic of China</country></aff></contrib-group><author-notes><corresp id="cor1"><label>CONTACT</label> Yi-Wei Tang <email xlink:href="yi-wei.tang@cepheid.com">yi-wei.tang@cepheid.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>30</day><month>3</month><year>2020</year></pub-date><volume>9</volume><issue>1</issue><fpage seq="83">747</fpage><lpage>756</lpage><history><date date-type="received"><day>25</day><month>2</month><year>2020</year></date><date date-type="rev-recd"><day>16</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>17</day><month>3</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 The Author(s). Published by Informa UK Limited, trading as
Taylor &#x00026; Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co.,
Ltd</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted
use, distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="TEMI_9_1745095.pdf"/><abstract><title>ABSTRACT</title><p>The three unprecedented outbreaks of emerging human coronavirus (HCoV) infections at the
beginning of the twenty-first century have highlighted the necessity for readily
available, accurate and fast diagnostic testing methods. The laboratory diagnostic methods
for human coronavirus infections have evolved substantially, with the development of novel
assays as well as the availability of updated tests for emerging ones. Newer laboratory
methods are fast, highly sensitive and specific, and are gradually replacing the
conventional gold standards. This presentation reviews the current laboratory methods
available for testing coronaviruses by focusing on the coronavirus disease 2019 (COVID-19)
outbreak going on in Wuhan. Viral pneumonias typically do not result in the production of
purulent sputum. Thus, a nasopharyngeal swab is usually the collection method used to
obtain a specimen for testing. Nasopharyngeal specimens may miss some infections; a deeper
specimen may need to be obtained by bronchoscopy. Alternatively, repeated testing can be
used because over time, the likelihood of the SARS-CoV-2 being present in the nasopharynx
increases. Several integrated, random-access, point-of-care molecular devices are
currently under development for fast and accurate diagnosis of SARS-CoV-2 infections.
These assays are simple, fast and safe and can be used in the local hospitals and clinics
bearing the burden of identifying and treating patients.</p></abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>Human coronavirus</kwd><kwd>SARS-CoV-2</kwd><kwd>COVID-19</kwd><kwd>POCT</kwd><kwd>real-time PCR</kwd><kwd>serology</kwd></kwd-group><counts><fig-count count="1"/><table-count count="3"/><equation-count count="0"/><ref-count count="70"/><page-count count="10"/></counts></article-meta></front><body><sec id="S001"><title>Agent</title><p>Coronaviruses belong to the family <italic>Coronaviridae</italic> which includes four
genera, <italic>Alphacoronavirus</italic>, <italic>Betacoronavirus</italic>,
<italic>Deltacoronavirus</italic> and <italic>Gammacoronavirus</italic>, as well as
several subgenera and species. Coronaviruses are found in a variety of animals and humans.
Human coronaviruses (HCoVs) include HCoV-229E and HCoV-NL63 in the genus
<italic>Alphacoronavirus</italic>, and HCoV-OC43 and HCoV-HKU1 in the A lineage (subgenus
<italic>Embecovirus</italic>) of genus <italic>Betacoronavirus</italic>. HCoVs were first
isolated in cell culture in the 1960s from persons with upper respiratory infections. These
were later characterized as HCoV-229E and HCoV-OC43 [<xref rid="CIT0001" ref-type="bibr">1</xref>]. HCoV-NL63 and HCoV-HKU1 were discovered in the early 2000s from persons with
bronchiolitis and pneumonia. In 2002 a <italic>Betacoronavirus</italic> in lineage B
(subgenus <italic>Sarbecovirus</italic>) originating in bats, then spread from civets to
humans in the Guangdong province of southern China, causing severe respiratory disease, and
taking the name severe acute respiratory syndrome-related coronavirus (SARS-CoV) [<xref rid="CIT0002" ref-type="bibr">2</xref>,<xref rid="CIT0003" ref-type="bibr">3</xref>]. In
2012 a <italic>Betacoronavirus</italic> in lineage C (subgenus
<italic>Merbecovirus</italic>) spread from camels to humans in Saudi Arabia, causing a
similar clinical syndrome as SARS, taking the name Middle East respiratory syndrome-related
coronavirus (MERS-CoV) [<xref rid="CIT0004" ref-type="bibr">4&#x02013;6</xref>].</p><p>The latest coronavirus to emerge in humans appeared in Wuhan City, Hubei Province, China in
December 2019 [<xref rid="CIT0007" ref-type="bibr">7</xref>,<xref rid="CIT0008" ref-type="bibr">8</xref>] and has been designated SARS-CoV-2 [<xref rid="CIT0009" ref-type="bibr">9</xref>]. Genomic sequencing shows SARS-CoV-2 to be closely related to
betacoronaviruses detected in bats (88% sequence identity), but distinct from SARS-CoV (79%
sequence identify) [<xref rid="CIT0008" ref-type="bibr">8</xref>,<xref rid="CIT0010" ref-type="bibr">10</xref>]. SARS-CoV-2 is taxonomically related to the subgenus
<italic>Sarbecovirus</italic> together with SARS-CoV and bat SARS-like CoVs [<xref rid="CIT0011" ref-type="bibr">11</xref>]. Phylogenomic evaluations of coronaviruses
circulating in China can be view in <ext-link ext-link-type="uri" xlink:href="http://diverge.hunter.cuny.edu/~weigang/mobile-cov/?from=singlemessage%26isappinstalled=0">http://diverge.hunter.cuny.edu/~weigang/mobile-cov/?from=singlemessage&#x00026;isappinstalled=0</ext-link>
(Accessed 1 March 2020).</p><p>Coronaviruses are enveloped viruses containing a single strand of positive-sense RNA.
Virions are mostly spherical, with pronounced spiked glycoprotein (S) embedded in the
envelope. Additional structural proteins include envelope (E), matrix (M), and nucleocapsid
(N). Intra- and inter-species transmission of CoVs, and genetic recombination events
contribute to the emergence of new CoV strains [<xref rid="CIT0001" ref-type="bibr">1</xref>].</p></sec><sec id="S002"><title>Clinical and public health significance</title><sec id="S002-S2001"><title>Epidemiology</title><p>HCoVs are endemic (HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1) or epidemic (SARS-CoV,
MERS-CoV and SARS-CoV-2). In temperate regions endemic HCoVs usually display a winter
seasonality, although HCoV-229E has been detected sporadically throughout the year [<xref rid="CIT0012" ref-type="bibr">12</xref>]. Endemic HCoVs are globally distributed and are
maintained in the human population. The SARS-CoV pandemic came to an end in 2003
(<ext-link ext-link-type="uri" xlink:href="https://www.who.int/csr/resources/publications/CDS_CSR_ARO_2004_2.pdf?ua=1">https://www.who.int/csr/resources/publications/CDS_CSR_ARO_2004_2.pdf?ua=1</ext-link>.
Accessed 3 February 2020), less than a year after the first reported case. In contrast,
human cases caused by MERS-CoV continue to be reported at the time of writing, more than
seven years after the first reported case. Most laboratory-confirmed MERS cases have
occurred in the Eastern Mediterranean Region, and the majority of those in Saudi Arabia.
Unlike the endemic HCoVs, SARS-CoV and MERS-CoV are maintained in zoonotic reservoirs. The
SARS and MERS outbreaks were driven in part by super-spreading events in which individuals
directly infected a disproportionally large number of contacts [<xref rid="CIT0013" ref-type="bibr">13</xref>]. The SARS-CoV-2-caused coronavirus disease 2019 (COVID-19)
epidemic originated in a Wuhan, China market that sold exotic animals for consumption.
Based on genetic relatedness to other betacoronaviruses, SARS-CoV-2 likely has a zoonotic
reservoir. However, the precise source of SARS-CoV-2 that initially infected humans
remains to be confirmed. The SARS-CoV-2 appears to be substantially more contagious than
SARS-CoV (<xref rid="T0001" ref-type="table">Table 1</xref>). The distribution of
SARS-CoV-2 in different mammalian species is unknown. An interesting question is the
susceptibility of farm animals and pets, and their role in the epidemiologic cycle as
their angiotensin-converting enzyme 2 (ACE2) receptor shares similarity with human ACE2
[<xref rid="CIT0014" ref-type="bibr">14</xref>]. <table-wrap id="T0001" orientation="portrait" position="float"><label>Table
1.</label><caption><title>Human coronaviruses.</title></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead valign="bottom"><tr><th align="left">Virus</th><th align="center">Genus</th><th align="center">Disease</th><th align="center">Discovered</th><th align="center">References</th></tr></thead><tbody><tr><td align="left">CoV-229E</td><td align="left">Alpha</td><td align="left">Mild respiratory tract
infection</td><td align="char" char=".">1967</td><td align="center">[<xref rid="CIT0031" ref-type="bibr">31</xref>]</td></tr><tr><td align="left">CoV-NL-63</td><td align="left">Alpha</td><td align="left">Mild respiratory tract
infection</td><td align="char" char=".">1965</td><td align="center">[<xref rid="CIT0032" ref-type="bibr">32</xref>]</td></tr><tr><td align="left">CoV-HKU-1</td><td align="left">Beta</td><td align="left">Mild respiratory tract infection;
pneumonia</td><td align="char" char=".">2005</td><td align="center">[<xref rid="CIT0054" ref-type="bibr">54</xref>]</td></tr><tr><td align="left">CoV-OC43</td><td align="left">Beta</td><td align="left">Mild respiratory tract
infection</td><td align="char" char=".">2004</td><td align="center">[<xref rid="CIT0068" ref-type="bibr">68</xref>]</td></tr><tr><td align="left">SARS-CoV</td><td align="left">Beta</td><td align="left">Human severe acute respiratory syndrome,
10% mortality rate</td><td align="char" char=".">2003</td><td align="center">[<xref rid="CIT0002" ref-type="bibr">2</xref>,<xref rid="CIT0003" ref-type="bibr">3</xref>]</td></tr><tr><td align="left">MERS-CoV</td><td align="left">Beta</td><td align="left">Human severe acute respiratory syndrome,
37% mortality rate</td><td align="char" char=".">2012</td><td align="center">[<xref rid="CIT0004 CIT0005 CIT0006" ref-type="bibr">4&#x02013;6</xref>]</td></tr><tr><td align="left">SARS-CoV-2</td><td align="left">Beta</td><td align="left">Severe acute respiratory infections,
&#x0003c;2% mortality rate</td><td align="char" char=".">2019</td><td align="center">[<xref rid="CIT0008" ref-type="bibr">8</xref>,<xref rid="CIT0020" ref-type="bibr">20</xref>,<xref rid="CIT0022" ref-type="bibr">22</xref>,<xref rid="CIT0059" ref-type="bibr">59</xref>]</td></tr></tbody></table></table-wrap></p></sec><sec id="S002-S2002"><title>Symptoms</title><p>Infections caused by endemic HCoVs have an incubation period of 2&#x02013;5 days and are
associated with mild upper respiratory symptoms (the &#x0201c;common cold&#x0201d;). Endemic HCoVs are
among the most frequent cause of upper respiratory tract infections. Lower respiratory
tract infections (bronchiolitis, pneumonia) are rare. Following an incubation period of
usually 4&#x02013;5 days, patients infected with SARS-CoV often present with symptoms of fever,
headache, and myalgias. Respiratory symptoms including cough and dyspnoea usually develop
from several days to a week after illness onset. Atypical pneumonia and respiratory
deterioration occur in 20&#x02013;30% of cases. The incubation period and clinical course of MERS
are similar to that of SARS, the exception being a higher proportion of cases progressing
to respiratory deterioration and distress. The incubation period and clinical course of
SARS-CoV-2 infection are probably similar to that of SARS. Li et al. first reported a mean
incubation period of 5.2 days [<xref rid="CIT0015" ref-type="bibr">15</xref>]. Fever and
cough are frequently reported early in the course of illness [<xref rid="CIT0016" ref-type="bibr">16</xref>,<xref rid="CIT0017" ref-type="bibr">17</xref>]. Infections are
also characterized by dyspnoea, respiratory distress and positive chest X-ray [<xref rid="CIT0010" ref-type="bibr">10</xref>]. Lower respiratory symptoms often develop about
1 week from the onset of initial symptoms [<xref rid="CIT0016" ref-type="bibr">16</xref>].</p></sec><sec id="S002-S2003"><title>Morbidity and mortality</title><p>Globally over 8000 cases and over 900 deaths due to SARS-CoV were reported, with a
case-fatality ratio of approximately 11% (<ext-link ext-link-type="uri" xlink:href="https://www.who.int/csr/sars/en/WHOconsensus.pdf">https://www.who.int/csr/sars/en/WHOconsensus.pdf</ext-link>. Accessed 3 February 2020).
Between September 2012 and November 2019, there were 2494 laboratory-confirmed cases of
MERS, with 858 deaths (<ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/mers-cov/en/">https://www.who.int/emergencies/mers-cov/en/</ext-link>. Accessed 4 February 2020). The
MERS case-fatality rate of 34.4% is about triple that of SARS, and persons in the 50&#x02013;59
year age group are at highest risk for primary cases. In the short time from its emergence
in December 2019 to 15 March 2020, the SARS-CoV-2 has been reported in 134 countries. At
the time of writing, the situation was evolving rapidly, with over 142,000 confirmed cases
reported globally (over 81,000 in China) and 3194 deaths in China (3.9% case-fatality
rate) and over 2100 deaths outside of China. Of countries and continents outside of China,
South Korea, Iran, and Europe (particularly Italy) have experienced a high number of
COVID-19 cases (<ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/</ext-link>.
Accessed 15 March 2020). Mortality rates vary widely, and depend on the age of patients,
underlying risk factors, and the denominator definition &#x02013; hospitalized cases, all
symptomatic cases, only moderate to severe cases, etc. In a study of adult patients (mean
age 59.7 y; 40% with chronic illnesses) with SARS-CoV-2 pneumonia admitted to the
intensive care unit (ICU), 61.5% died within 28 days [<xref rid="CIT0018" ref-type="bibr">18</xref>]. In contrast, a study of hospitalized patients (median age 47.5 years)
across Beijing showed 18% of cases to be severe and 73% mild, with a fatality rate of 0.9%
[<xref rid="CIT0019" ref-type="bibr">19</xref>]. Mortality is highest in older persons,
with a median age of 59&#x02013;75 years [<xref rid="CIT0015" ref-type="bibr">15</xref>,<xref rid="CIT0017" ref-type="bibr">17</xref>]. Treatment for all severe HCoV infections is
supportive although a randomized, double-blinded, control clinical trial has been
conducted on a Gilead drug Remdesivir [<xref rid="CIT0020" ref-type="bibr">20</xref>]
Based on one study focused on children, a total of 28 children aged from 1 month to 17
years have been reported in China. All paediatric cases with laboratory-confirmed
SARS-CoV-2 infection were mild cases with no deaths reported [<xref rid="CIT0021" ref-type="bibr">21</xref>]. During the first 2 months of the current outbreak, COVID-19
spread rapidly throughout China and caused varying degrees of illness with a death rate of
1.3%. Patients often presented without fever, and many did not have abnormal radiologic
findings [<xref rid="CIT0022" ref-type="bibr">22</xref>].</p><p>The Chinese Centers for Disease Control and Prevention team analysed more than 72,000
patient records, of which 44,672 were laboratory-confirmed cases, 16,186 suspected cases,
10,567 clinically diagnosed cases, and 889 asymptomatic cases. Of the confirmed cases,
about 14% of the illnesses were severe, which included pneumonia and shortness of breath,
and about 5% have the critical disease, marked by respiratory failure, septic shock, and
multi-organ failure. The overall case-fatality rate was 2.3%, and of 1023 deaths included
in the study, the majority were in people age 60 and older or those with underlying
medical conditions <ext-link ext-link-type="uri" xlink:href="http://www.cidrap.umn.edu/news-perspective/2020/02/more-outbreak-details-emerge-covid-19-cases-top-70000">http://www.cidrap.umn.edu/news-perspective/2020/02/more-outbreak-details-emerge-covid-19-cases-top-70000</ext-link>
(Accessed 18 February 2020).</p></sec></sec><sec id="S003"><title>Laboratory diagnosis</title><sec id="S003-S2001"><title>Specimen collection</title><p>It must be appreciated that no matter how accurate and fast laboratory testing methods
are, the diagnosis of viral pneumonias such as caused by SARS-CoV-2 involves collecting
the correct specimen from the patient at the right time. The endemic HCoVs have been
detected from a variety of upper and lower respiratory sources including throat, nasal
nasopharyngeal (NP), sputum, and bronchial fluid [<xref rid="CIT0012" ref-type="bibr">12</xref>,<xref rid="CIT0023" ref-type="bibr">23</xref>,<xref rid="CIT0024" ref-type="bibr">24</xref>]. Wang et al have just reported that oropharyngeal (OP) swabs
(<italic>n</italic>&#x02009;=&#x02009;398) were used much more frequently than NP swabs
(<italic>n</italic>&#x02009;=&#x02009;8) in China during the COVID-19 outbreak; however, the SARS-CoV-2
RNA was detected only in 32% of OP swabs, which was significantly lower than that in NP
swabs (63%)[<xref rid="CIT0025" ref-type="bibr">25</xref>]. The US centers for disease
control and prevention (CDC) recommends collecting the upper respiratory NP swab.
Collection of an OP specimen is a lower priority, and, if collected, should be combined in
the same tube as the NP swab (<ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html">https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html</ext-link>.
Accessed 16 March 2020). Swab specimens should be placed in a universal or viral transport
medium. Nasopharyngeal aspirates are also suitable specimens for the detection of
HCoVs.</p><p>For the most sensitive detection of SARS-CoV, MERS-CoV, and SARS-CoV-2, the collection
and testing of both upper and lower respiratory samples [sputum, bronchoalveolar lavage
fluid (BAL)] is recommended [<xref rid="CIT0026" ref-type="bibr">26</xref>]. However, the
collection of sputum and particularly BAL via bronchoscopy increases biosafety risk to
healthcare workers through the creation of aerosol droplets. Proper use of personal
protective equipment (PPE) by healthcare workers is important. Bronchoscopy is a highly
technical procedure requiring well-trained staff and may not be available in many parts of
the world. Upper respiratory specimens are easy to collect, thereby increasing access to
testing for patients with mild symptoms, and in the resource limited settings. SARS-CoV
and MERS-CoV RNA are also detected from stool, urine and blood specimens, although
generally less reliably than from respiratory specimens [<xref rid="CIT0026" ref-type="bibr">26&#x02013;28</xref>]. An exception is SARS-CoV
RNA which is consistently detected in feces at about two weeks after symptom onset [<xref rid="CIT0026" ref-type="bibr">26</xref>,<xref rid="CIT0029" ref-type="bibr">29</xref>].
For the most sensitive detection of endemic HCoVs, upper respiratory specimens should be
collected within the first few days of symptom onset. The dynamics of RNA shedding in MERS
and SARS patients may reflect the specimen source, severity of illness, as well as
underlying risk factors. Among hospitalized patients who did not require ventilator
support, MERS-CoV RNA levels in the upper respiratory tract usually peaked in the first
week after symptom onset. Among eventual fatal cases requiring ventilation, RNA levels in
lower respiratory tract specimens peaked between weeks 2 and 3 [<xref rid="CIT0027" ref-type="bibr">27</xref>]. Similar shedding patterns were seen for SARS-CoV: RNA
positive rates peaked in upper respiratory tract specimens at 7&#x02013;10 days after symptom
onset and then steadily declined after that, while RNA positive rates in lower respiratory
tract specimens remained higher throughout 3 weeks after onset of illness [<xref rid="CIT0026" ref-type="bibr">26</xref>]. In one study, diabetes was associated with
prolonged MERS-CoV RNA shedding in the respiratory tract [<xref rid="CIT0027" ref-type="bibr">27</xref>].</p><p>Viral pneumonias typically do not result in the production of purulent sputum. Thus, a
nasopharyngeal swab/wash is usually the collection method used to obtain a specimen for
testing. Nasopharyngeal specimens may miss early infection; a deeper specimen may need to
be obtained by bronchoscopy. Alternatively, repeated testing can be used because over
time, the likelihood of the SARS-CoV-2 being present in the nasopharynx increases.
Self-collected saliva specimens were tested positive in 11 of 12 COVID-19 patients,
suggesting it is a promising non-invasive specimen for diagnosis, monitoring, and
infection control in SARS-CoV-2 infections [<xref rid="CIT0030" ref-type="bibr">30</xref>]. At the time of writing there was little data on the performance of upper vs.
lower respiratory tract specimens for the detection of SARS-CoV-2 [<xref rid="CIT0016" ref-type="bibr">16</xref>]. Serum is another source for the detection of SARS-CoV-2.
However, only 15% of patients hospitalized with pneumonia had detectable RNA in serum
[<xref rid="CIT0016" ref-type="bibr">16</xref>]. Specimens collected for laboratory
testing of HCoVs should be maintained at refrigerated temperature for up to 72 h, or
frozen at &#x02212;70&#x000b0;C or below (<ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html">https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html</ext-link>.
Accessed 15 March 2020). Rectal specimens have been reported positive in patients infected
with SARS-CoV-2 [<xref rid="CIT0020" ref-type="bibr">20</xref>].</p></sec><sec id="S003-S2002"><title>Biosafety considerations</title><p>If the patient&#x02019;s travel or exposure history or symptoms suggest possible infection with a
high-risk, novel agent, SARS-CoV, or MERS-CoV, then the initial handling of the specimen
should be performed under biosafety level 3 (BSL-3) conditions until the specimen or an
aliquot is rendered noninfectious by lysis or another method. Virus isolation should not
be routinely performed in this situation (<ext-link ext-link-type="uri" xlink:href="https://www.asm.org/Articles/Policy/Laboratory-Response-Network-LRN-Sentinel-Level-C">https://www.asm.org/Articles/Policy/Laboratory-Response-Network-LRN-Sentinel-Level-C</ext-link>.
Accessed 4 February 2020). The U.S. CDC biosafety guidelines state that routine diagnostic
testing of specimens from suspected or confirmed SARS-CoV-2 patients, can be handled in a
BSL-2 laboratory using standard precautions (<ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html">https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html</ext-link>.
Accessed 21 March 2020).</p></sec><sec id="S003-S2003"><title>Cell culture</title><p>Isolation of HCoVs in cell culture is not routinely performed for diagnostic purposes due
to the lack of permissive cell lines, time to results, labour and expertise requirements,
and the lack of commercial antisera for culture confirmation (<xref rid="T0002" ref-type="table">Table 2</xref>). SARS-CoV and MERS-CoV and SARS-CoV-2 will grow in
primary monkey cells and cell lines such as Vero and LLC-MK2, but cell culture should not
be performed for suspect cases in routine diagnostic laboratories for biosafety reasons
[<xref rid="CIT0002" ref-type="bibr">2</xref>,<xref rid="CIT0006" ref-type="bibr">6</xref>,<xref rid="CIT0031" ref-type="bibr">31</xref>,<xref rid="CIT0032" ref-type="bibr">32</xref>]. However, virus isolation in cell cultures is critical to
obtain isolates for characterization and to support the development of vaccines and
therapeutic agents. <table-wrap id="T0002" orientation="portrait" position="float"><label>Table
2.</label><caption><title>Laboratory techniques for detection of
coronaviruses.</title></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead valign="bottom"><tr><th align="left">Method</th><th align="center">Characteristics</th><th align="center">Test time</th><th align="center">Application</th><th align="center">Reference</th></tr></thead><tbody><tr><td align="left">Antigen EIA</td><td align="left">Rapid, poor sensitivity, some are
CLIA-waived</td><td align="left">&#x0003c;30&#x02005;min</td><td align="left">Diagnosis (detection)</td><td align="left">[<xref rid="CIT0033 CIT0034 CIT0035" ref-type="bibr">33&#x02013;35</xref>]</td></tr><tr><td align="left">Antigen IFA</td><td align="left">Good sensitivity and specificity,
subjective interpretation</td><td align="left">1&#x02013;4&#x02005;h</td><td align="left">Diagnosis (detection)</td><td align="left">[<xref rid="CIT0036" ref-type="bibr">36</xref>,<xref rid="CIT0037" ref-type="bibr">37</xref>]</td></tr><tr><td align="left">Cell culture</td><td align="left">Gold standard, pure culture for further
research and development, time consuming</td><td align="left">1&#x02013;7 days</td><td align="left">Diagnosis (detection, differentiation,
typing and characterization) and research</td><td align="left">[<xref rid="CIT0002" ref-type="bibr">2</xref>,<xref rid="CIT0006" ref-type="bibr">6</xref>,<xref rid="CIT0031" ref-type="bibr">31</xref>,<xref rid="CIT0032" ref-type="bibr">32</xref>]</td></tr><tr><td align="left">Serology</td><td align="left">Retrospective,
cross-reaction</td><td align="left">2&#x02013;8&#x02005;h</td><td align="left">Infection confirmation, epidemiology and
research, vaccine evaluation</td><td align="left">[<xref rid="CIT0002" ref-type="bibr">2</xref>,<xref rid="CIT0003" ref-type="bibr">3</xref>,<xref rid="CIT0040 CIT0041 CIT0042" ref-type="bibr">40&#x02013;42</xref>]</td></tr><tr><td align="left">NAAT, monoplex, pan-HCoV</td><td align="left">High sensitivity with universal coverage
of all species of HCoV</td><td align="left">1&#x02013;8&#x02005;h</td><td align="left">Diagnosis (detection), discovery and
research</td><td align="left">[<xref rid="CIT0052 CIT0053 CIT0054" ref-type="bibr">52&#x02013;54</xref>]</td></tr><tr><td align="left">NAAT, monoplex,
specific-HCoV</td><td align="left">High sensitivity and specificity for
special species, potential quantification</td><td align="left">1&#x02013;8&#x02005;h</td><td align="left">Diagnosis (detection, differentiation,
and limited typing) and research</td><td align="left">[<xref rid="CIT0069" ref-type="bibr">69</xref>,<xref rid="CIT0070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left">NAAT, multiplex</td><td align="left">High sensitivity and specificity,
covering other pathogens, FilmArray RP EZ is CLIA-waived</td><td align="left">1&#x02013;8 h</td><td align="left">Diagnosis (detection, differentiation,
and limited typing) and research</td><td align="left">[<xref rid="CIT0012" ref-type="bibr">12</xref>,<xref rid="CIT0055 CIT0056 CIT0057" ref-type="bibr">55&#x02013;57</xref>]</td></tr><tr><td align="left">NAAT, POCT</td><td align="left">Rapid and safe, good sensitivity and
specificity, some are CLIA-waived</td><td align="left">15&#x02013;30&#x02005;min</td><td align="left">Diagnosis (detection and limited
differentiation) and research</td><td align="left">[<xref rid="CIT0063" ref-type="bibr">63</xref>,<xref rid="CIT0067" ref-type="bibr">67</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic>Note:</italic> EIA, enzyme immunoassay; IFA, immunofluorescent assay; NAAT,
nucleic acid amplification test; CLIA, Clinical Laboratory Improvement Act.</p></table-wrap-foot></table-wrap></p></sec><sec id="S003-S2004"><title>Rapid antigen tests</title><p>Rapid antigen tests would theoretically provide the advantage of fast time to results and
low-cost detection of HCoVs but are likely to suffer from poor sensitivity based on the
experience with this method for influenza (Flu) viruses [<xref rid="CIT0033" ref-type="bibr">33&#x02013;37</xref>] (<xref rid="T0002" ref-type="table">Table 2</xref>). In a pre-peer reviewed article, Diao et
al. reported that a fluorescence immunochromatographic assay is an accurate, rapid, early
and simple method for detecting nucleocapsid protein of SARS-CoV-2 in NP swab for
diagnosis of COVID-19 (<ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.03.07.20032524v2">https://www.medrxiv.org/content/10.1101/2020.03.07.20032524v2</ext-link>. Accessed 15
March 2020). The incorporation of colloidal gold-labeled immunoglobulin G (IgG) as the
detection reagent is an approach that may increase the sensitivity of rapid antigen tests
for respiratory viruses [<xref rid="CIT0038" ref-type="bibr">38</xref>]<sans-serif>.</sans-serif> Monoclonal antibodies specifically against
SARS-CoV-2 have been under preparation. Novel approaches to concentrate antigen, or to
amplify the detection phase are needed if these methods are to have clinical utility. Sona
Nanotech (Halifax, Canada) is developing a quick-response lateral-flow test to screen
COVID-19 patients targeting to produce results in 5&#x02013;15 min (<ext-link ext-link-type="uri" xlink:href="https://sonanano.com/sona-develops-rapid-screening-test-for-coronavirus/">https://sonanano.com/sona-develops-rapid-screening-test-for-coronavirus/</ext-link>.
Accessed 15 February 2020). Timing of specimen collection, when viral titres are highest,
may improve the diagnostic sensitivity of rapid antigen tests for HCoVs [<xref rid="CIT0039" ref-type="bibr">39</xref>].</p></sec><sec id="S003-S2005"><title>Serology</title><p>Serological assays are not routinely used for diagnosis of HCoV infections due to the
lack of commercial reagents, let alone commercial reagents that have been vetted by
clinical trials and the regulatory review process [<xref rid="CIT0040" ref-type="bibr">40</xref>,<xref rid="CIT0041" ref-type="bibr">41</xref>] (<xref rid="T0002" ref-type="table">Table 2</xref>). Serological assays, on the other hand, are important
for understanding the epidemiology of emerging HCoVs, including the burden and role of
asymptomatic infections.</p><p>It has been particularly important for antibody detection in the diagnosis of cases of
novel and emerging HCoVs, such as SARS-CoV and MERS-CoV [<xref rid="CIT0002" ref-type="bibr">2</xref>,<xref rid="CIT0003" ref-type="bibr">3</xref>]. In these
situations, affected patients may not test positive for viral RNA, particularly in the
early phase of the disease, but retrospectively can be shown to have developed an immune
response. When SARS-CoV-2 was identified, especially when rapid antigen testing and/or
molecular assays are neither available nor stable, serology can be used as a supplementary
diagnostic tool. A recent study demonstrated that both IgM and IgG antibodies were
detected 5 days after onset in all 39 patients infected with SARS-CoV-2 infection. The
authors recommended to use serology to facilitate the diagnosis of SARS-CoV-2 infections
when an NP swab specimen was collected inappropriately and the molecular assays were
performed unsatisfactorily [<xref rid="CIT0042" ref-type="bibr">42</xref>]. In China, six
serology devices have just received urgent approval from the National Medical Products
Administration (NMPA) by 12 March 2020 (<xref rid="T0003" ref-type="table">Table
3</xref>). Proper specimen handling and storage are important to maintain the integrity of
specimens and the performance of serologic tests. <table-wrap id="T0003" orientation="landscape" position="float"><label>Table 3.</label><caption><title>Diagnostic devices
cleared in China for laboratory diagnosis of SARS-CoV-2
infections.</title></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead valign="bottom"><tr><th align="left">Registration number</th><th align="center">Manufacturer</th><th align="center">Date registered</th><th align="center">Specimen type</th><th align="center">Principle and method</th><th align="center">Instrument</th><th align="center">Targets</th><th align="center">Remarks</th></tr></thead><tbody><tr><td align="left">20203400057</td><td align="left">Shanghai ZJ Bio-Tech</td><td align="left">26 January 2020</td><td align="left">Sputum, BAL, NPS</td><td align="left">Fluorescence RT-PCR</td><td align="left">Real-time thermocycler, e.g. ABI 7500
Fast Dx Real-Time PCR Instrument</td><td align="left">ORF1ab, E, N</td><td align="left">LOD: 1000 copies/ml</td></tr><tr><td align="left">20203400058</td><td align="left">Shanghai GeneoDx Biotech</td><td align="left">26 January 2020</td><td align="left">Sputum, pharyngeal swab</td><td align="left">Fluorescence RT-PCR</td><td align="left">Real-time thermocycler, e.g. ABI 7500
Fast Dx Real-Time PCR Instrument</td><td align="left">ORF1ab, N</td><td align="left">&#x000a0;</td></tr><tr><td align="left">20203400060</td><td align="left">BGI Biotech (Wuhan)</td><td align="left">26 January 2020</td><td align="left">BAL, pharyngeal swab</td><td align="left">Fluorescence RT-PCR</td><td align="left">Real-time thermocycler, e.g. ABI 7500
Fast Dx Real-Time PCR Instrument</td><td align="left">ORF1ab</td><td align="left">Single target</td></tr><tr><td align="left">20203400061</td><td align="left">MGI Tech</td><td align="left">26 January 2020</td><td align="left">Undefined</td><td align="left">NGS</td><td align="left">Genetic sequencer
(DNBSEQ-T7)</td><td align="left">Microbial DNA and RNA including
SARS-CoV-2 genome</td><td align="left">&#x000a0;</td></tr><tr><td align="left">20203400063</td><td align="left">Da An Gene</td><td align="left">28 January 2020</td><td align="left">Pharyngeal swab, sputum</td><td align="left">Fluorescence RT-PCR</td><td align="left">Real-time thermocycler, e.g. ABI 7500
Fast Dx Real-Time PCR Instrument</td><td align="left">ORF1ab, N and IC</td><td align="left">LOD, 500 copies/ml</td></tr><tr><td align="left">20203400064</td><td align="left">Sansure Biotech</td><td align="left">28 January 2020</td><td align="left">NPS, BAL</td><td align="left">Fluorescence RT-PCR</td><td align="left">Real-time thermocycler, e.g. ABI 7500
Fast Dx Real-Time PCR Instrument</td><td align="left">ORF1ab, N, IC</td><td align="left">LOD, 200 copies/ml; One-step RNA with 10
min specimen pretreatment</td></tr><tr><td align="left">20203400065</td><td align="left">Shanghai BioGerm Medical
Biotech</td><td align="left">31 January 2020</td><td align="left">NPS, OPS, sputum</td><td align="left">Fluorescence RT-PCR</td><td align="left">Real-time thermocycler, e.g. ABI 7500
Fast Dx Real-Time PCR Instrument</td><td align="left">ORF1ab, N</td><td align="left">&#x000a0;</td></tr><tr><td align="left">20203400176</td><td align="left">Wongfo Biotech</td><td align="left">22 February 2020</td><td align="left">Serum, plasma, whole blood</td><td align="left">Immune colloidal gold
technique</td><td align="left">Not needed</td><td align="left">Antibody against SARS-CoV-2</td><td align="left">&#x000a0;</td></tr><tr><td align="left">20203400177</td><td align="left">Innovita Biological
Technology</td><td align="left">22 February 2020</td><td align="left">Serum, plasma</td><td align="left">Immune colloidal gold
technique</td><td align="left">Not needed</td><td align="left">IgM/IgG antibody against
SARS-CoV-2</td><td align="left">&#x000a0;</td></tr><tr><td align="left">20203400178</td><td align="left">CapitalBio (Chengdu)</td><td align="left">22 February 2020</td><td align="left">NPS</td><td align="left">Isothermal amplification and
microarray</td><td align="left">RTisochip&#x02122;-A (20173401354)</td><td align="left">S, N and IC. Also covers Flu A
(universal, H1N1, H3N2), Flu B and RSV</td><td align="left">LOD, 50 copies/reaction; Total TAT,1.5
h</td></tr><tr><td align="left">20203400179</td><td align="left">Beijing Applied Biological Technologies
(X-ABT)</td><td align="left">27 February 2020</td><td align="left">Sputum, NPS</td><td align="left">Fluorescence RT-PCR</td><td align="left">Real-time thermocycler, e.g. ABI 7500
Fast Dx Real-Time PCR Instrument</td><td align="left">ORF1ab, N, E, IC</td><td align="left">LOD, 200 copies/ml; TAT, 90
min</td></tr><tr><td align="left">20203400182</td><td align="left">Bioscience (Chongqing)</td><td align="left">1 March 2020</td><td align="left">Serum</td><td align="left">Magnetic particle
chemiluminescence</td><td align="left">Automated magnetic analyser: Axceed
260</td><td align="left">IgM antibody against
SARS-CoV-2</td><td align="left">&#x000a0;</td></tr><tr><td align="left">20203400183</td><td align="left">Bioscience (Chongqing)</td><td align="left">1 March 2020</td><td align="left">Serum</td><td align="left">Magnetic particle
chemiluminescence</td><td align="left">Automated magnetic analyser: Axceed
260</td><td align="left">IgG antibody against
SARS-CoV-2</td><td align="left">&#x000a0;</td></tr><tr><td align="left">20203400184</td><td align="left">Maccura Biotechnology</td><td align="left">1 March 2020</td><td align="left">Pharyngeal swab, sputum</td><td align="left">Fluorescence RT-PCR</td><td align="left">Real-time thermocycler, e.g. ABI 7500
Fast Dx Real-Time PCR Instrument</td><td align="left">ORF1ab, N, E</td><td align="left">&#x000a0;</td></tr><tr><td align="left">20203400198</td><td align="left">Xiamen Wantai Kairui
Biotechnology</td><td align="left">6 March 2020</td><td align="left">Serum, plasma</td><td align="left">Chemiluminescence
immunoassay</td><td align="left">Caris 200 Automatic Chemiluminescence
Analyser</td><td align="left">Total antibody (IgM, IgG and IgA) against
SARS-CoV-2</td><td align="left">TAT, 29 min; Throughput, 400 tests/hour;
Sensitivity, 94.8%; Specificity, 99.7%</td></tr><tr><td align="left">20203400199</td><td align="left">Guangdong Hecin-Scientific</td><td align="left">11 March 2020</td><td align="left">Serum, plasma</td><td align="left">Immune colloidal gold
technique</td><td align="left">Not needed</td><td align="left">IgM antibody against
SARS-CoV-2</td><td align="left">&#x000a0;</td></tr><tr><td align="left">20203400212</td><td align="left">Wuhan Easydiagnosis
Biomedicine</td><td align="left">12 March 2020</td><td align="left">NPS, OPS, sputum</td><td align="left">Fluorescence RT-PCR</td><td align="left">Real-time thermocycler, e.g. ABI 7500
Fast Dx Real-Time PCR Instrument</td><td align="left">ORF1ab, N</td><td align="left">&#x000a0;</td></tr></tbody></table><table-wrap-foot><p><italic>Note:</italic> LOD, limit of detection; TAT, turnaround time; NPS,
nasopharyngeal swabs; OPS, oropharyngeal swabs; BAL, bronchoalveolar lavage; NGS,
next-generation sequencing; Flu, influenza; RSV, respiratory syncytial virus.</p></table-wrap-foot></table-wrap></p></sec><sec id="S003-S2006"><title>Molecular methods</title><p>Random-amplification deep-sequencing approaches played a critical role in identifying
MERS-CoV and SARS-CoV-2 [<xref rid="CIT0006" ref-type="bibr">6</xref>,<xref rid="CIT0011" ref-type="bibr">11</xref>,<xref rid="CIT0043" ref-type="bibr">43&#x02013;47</xref>]. For the clinical diagnostic application, the genetic
heterogeneity of HCoVs precludes a single &#x0201c;pan-HCoV&#x0201d; molecular assay [<xref rid="CIT0048" ref-type="bibr">48&#x02013;51</xref>] (<xref rid="T0002" ref-type="table">Table 2</xref>). Some pan-CoV assays use degenerate primers [<xref rid="CIT0052" ref-type="bibr">52</xref>], some utilize multiple primer sets [<xref rid="CIT0053" ref-type="bibr">53</xref>], and others employ a single set of
nondegenerate primers [<xref rid="CIT0054" ref-type="bibr">54</xref>]. Current molecular
respiratory panels that detect the endemic HCoVs (HCoV-NL63, HCoV-HKU1, HCoV-OC43, and
HCoV-229E) require multiple sets of PCR oligonucleotides [<xref rid="CIT0012" ref-type="bibr">12</xref>,<xref rid="CIT0055" ref-type="bibr">55&#x02013;57</xref>]. SARS-CoV-2 cases tested negative for endemic HCoVs included in molecular
respiratory panels [<xref rid="CIT0010" ref-type="bibr">10</xref>].</p><p>In China, at the time of revising, eleven molecular devices from Shanghai ZJ Bio-Tech,
Shanghai GeneoDx Biotech, BGI Biotech (Wuhan), MGI Tech, Da An Gene, Sansure Biotech,
Shanghai BioGerm Medical Biotech Capitalbio (Chengdu), Beijing Applied Biological
Technologies, Maccura Biotechnology, and Wuhan Easydiagnosis Biomedicine have received
urgent approval from NMPA and their characteristics are contrasted in <xref rid="T0003" ref-type="table">Table 3</xref>. Variable performance has been reported on these devices
[<xref rid="CIT0047" ref-type="bibr">47</xref>,<xref rid="CIT0058" ref-type="bibr">58</xref>]. In their registration certificates, it was clearly indicated that the
certificate was for urgent and supplemental diagnosis of pneumonia caused by SARS-CoV-2.
Additional multi-centre clinical trial data are needed for extension after one year. Among
them, one (MGI Tech) uses its NGS technique to detect all pathogens in a given specimen
including SARS-CoV-2 and the other one (Innovita) uses its isothermal amplification
followed by chip detection. The other nine devices incorporated real-time PCR technique
with hydrolysis probes. After nucleic acids get extracted (separated reagents and
systems), the extracts are transferred to a real-time PCR thermocycler (e.g. ABI 7500 Fast
Dx Real-Time PCR Instrument) for nucleic acid amplification and detection.</p><p>Several RT-PCR protocols for detection of SARS-CoV-2 RNA have been posted by the World
Health Organization at <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance</ext-link>.
(Accessed 15 March 2020). Three of these protocols are listed below.</p><p>The US CDC developed developed a RT-PCR Diagnostic Panel for universal detection of
SARS-like betacoronaviruses and specific detection of SARS-CoV-2 [<xref rid="CIT0020" ref-type="bibr">20</xref>]. Three separate RT-PCR reactions target the N gene. One
primer/probe set detects all betacoronaviruses, while two sets are specific for
SARS-CoV-2. All 3 assays must be positive to report presumptive positive for SARS-CoV-2
(<ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/media/134922/download">https://www.fda.gov/media/134922/download</ext-link>. Accessed 15 March 2020). Specimen
types included upper and lower respiratory specimens (such as NP or OP swabs, sputum,
lower respiratory tract aspirates, BAL, and nasopharyngeal wash/aspirate or nasal
aspirate). It received emergency use authorization (EUA) on 4 February 2020. At the time
of revision, the US Food and Drug Administration (FDA) has granted thirteen in vitro
diagnostics EUAs: the aforementioned CDC assay; the New York SARS-CoV-2 Real-time RT-PCR
Diagnostic Panel (Wadsworth Center, New York State Department of Health); TaqPath COVID-19
Combo Kit (Thermo Fisher Scientific, Inc.); cobas SARS-CoV-2 (Roche Molecular Systems,
Inc.; Panther Fusion SARS-CoV-2 (Hologic, Inc.); COVID-19 RT-PCR Test (Laboratory
Corporation of America); Lyra SARS-CoV-2 Assay (Quidel Corp.); Quest SARS-CoV-2 rRT-PCR
(Quest Diagnostics Infectious Disease, Inc.); Abbott RealTime SARS-CoV-2 assay (Abbott
Molecular); Simplexa COVID-19 Direct (DiaSorin Molecular LLC); ePlex SARS-CoV-2 Test
(GenMark Diagnostics, Inc.); Primerdesign Ltd COVID-19 genesig Real-Time PCR assay
(Primerdesign Ltd); and Xpert Xpress SARS-CoV-2 test (Cepheid) (<ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations#coronavirus2019">https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations#coronavirus2019</ext-link>.
Accessed 21 March 2020). Additional in vitro diagnostic assays are in development.</p><p>The Charit&#x000e9; algorithm (Berlin, Germany) begins with two RT-PCR assays that detect E and
RdRp genes of subgenus <italic>Sarbecovirus</italic> (SARS-CoV, SARS-CoV-2, and
bat-associated betacoronaviruses). Both assays must be positive to advance to the next
step in the testing algorithm. The second step consists of a SARS-CoV-2 specific RT-PCR
that targets RdRp [<xref rid="CIT0059" ref-type="bibr">59</xref>,<xref rid="CIT0060" ref-type="bibr">60</xref>]. Exclusivity testing showed that alphacoronaviruses (CoV-NL63
and &#x02212;229E) and betacoronaviruses HCoV-OC43, HCoV-HKU1 and MERS-CoV were not detected
(<ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2">https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2</ext-link>.
Accessed 8 February 2020).</p><p><italic>The University of Hong Kong Li Ka Shing Faculty of Medicine</italic> protocol
uses two assays (N gene screening assay followed by Orf1b assay for confirmation) to
detect subgenus <italic>Sarbecovirus</italic> [<xref rid="CIT0030" ref-type="bibr">30</xref>,<xref rid="CIT0061" ref-type="bibr">61</xref>]. Since SARS-CoV is not
circulating in humans currently, cases that are positive should be considered as
SARS-CoV-2 infected cases. Exclusivity testing showed that 229E, OC43 and MERS, 229E,
HKU1, NL63, OC43 yielded negative results (<ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/coronaviruse/peiris-protocol-16-1-20.pdf?sfvrsn=af1aac73_4">https://www.who.int/docs/default-source/coronaviruse/peiris-protocol-16-1-20.pdf?sfvrsn=af1aac73_4</ext-link>.
Accessed 8 February 2020).</p></sec></sec><sec id="S004"><title>Future direction</title><p>All three novel coronaviruses are highly contagious. Fast, safe, simple to use diagnostic
devices performed at or near the point of care (POC) (<xref rid="F0001" ref-type="fig">Figure 1</xref>) which have been shown to impact patient management and control of
infectious disease epidemics [<xref rid="CIT0062" ref-type="bibr">62</xref>], are extremely
desirable in POC when biosafety facility is limited (<xref rid="T0003" ref-type="table">Table 3</xref>). Several manufactures have been spending efforts to generate devices for
POC testing (POCT) [<xref rid="CIT0063" ref-type="bibr">63</xref>]. The ID NOW&#x02122; (previously
Alere i) Influenza A &#x00026; B assay (Abbott, San Diego, CA) was cleared by the US FDA for
direct use on NP swabs as the first-ever Clinical Laboratory Improvement Amendments
(CLIA)-waived nucleic acid-based test in January 2016 [<xref rid="CIT0064" ref-type="bibr">64</xref>,<xref rid="CIT0065" ref-type="bibr">65</xref>]. Similarly, the
Xpert<sup>&#x000ae;</sup> Xpress Flu/RSV (Cepheid, Sunnyvale, CA) and cobas<sup>&#x000ae;</sup>
Liat<sup>&#x000ae;</sup> Flu A/B &#x00026; RSV (Roche Molecular Systems, Pleasanton, CA) assays are
integrated nucleic acid extraction-independent devices that have recently received FDA
clearance and CLIA-waiver for simultaneous detection and identification of FluA, FluB, and
RSV in nasopharyngeal swabs [<xref rid="CIT0066" ref-type="bibr">66</xref>]. The
FilmArray<sup>&#x000ae;</sup> Respiratory EZ Panel (BioFire, Salt Lake City, UT) so far so far is
the only CLIA-waived syndromic panel that covers a set of 14 respiratory viral and bacterial
pathogens including classical coronavirus species [<xref rid="CIT0067" ref-type="bibr">67</xref>]. <fig id="F0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Evolutions in molecular testing procedures. The point-of-care test (POCT)
devices incorporate nucleic acid extraction, amplification and detection together into
an integrated and sealed cartridge making it simple, rapid and safe. During end-point
PCR, DNA is detected or measured at the completion of PCR amplification, requiring
post-PCR processing. Real-time PCR is a closed-tube system in which DNA is detected or
measured during the exponential phase of amplification.</p></caption><graphic xlink:href="TEMI_A_1745095_F0001_OC"/></fig></p><p>Considering the increased levels of mortality and infectivity associated with three
novel-coronavirus outbreaks, these random-access, safe and simple tests, which offer fast
and accurate detection and identification, are likely to have an immediate impact on prompt
clinical and epidemiological decisions [<xref rid="CIT0007" ref-type="bibr">7</xref>,<xref rid="CIT0063" ref-type="bibr">63</xref>]. Lysis buffer can be used to inactivate the
infectivity of specimens so the testing can be run at POC when a biosafety cabinet is not
available. Fast near-patient and POCT could help more efficiently triage of suspected cases
of novel coronavirus, helping to focus limited resources on enabling appropriate use of
quarantine. A handful of diagnostics developers are now striving to bring fast SARS-CoV-2
tests to market as soon as possible, with hopes of ultimately assisting with the ongoing
outbreak in China. Molecular diagnostic tests for use at the are in development from Cepheid
and HiberGene (Dublin, Ireland). Cepheid has some advantages in the molecular POCT space
because it already has instruments placed in China. Mobidiag, meanwhile, may offer
additional benefits with a multiplex test for coronavirus and Flu viruses (<ext-link ext-link-type="uri" xlink:href="https://www.genomeweb.com/pcr/diagnostics-firms-rush-develop-rapid-point-care-tests-novel-coronavirus#.XkeA3SgzY2x">https://www.genomeweb.com/pcr/diagnostics-firms-rush-develop-rapid-point-care-tests-novel-coronavirus#.XkeA3SgzY2x</ext-link>.
Accessed 15 February 2020).</p></sec></body><back><sec id="S005"><title>Disclosure statement</title><p>MJL and Y-WT are employees of Cepheid, the commercial manufacturer of the Xpert Xpress
SARS-CoV-2 test.</p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>W</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Epidemiology, genetic recombination, and Pathogenesis of
coronaviruses</article-title>. <source>Trends Microbiol</source>
<year>2016</year>;<volume>24</volume>(<issue>6</issue>):<fpage>490</fpage>&#x02013;<lpage>502</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/j.tim.2016.03.003</pub-id><pub-id pub-id-type="pmid">27012512</pub-id></mixed-citation></ref><ref id="CIT0002"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ksiazek</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Erdman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Goldsmith</surname><given-names>CS</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A novel coronavirus associated with severe acute respiratory
syndrome</article-title>. <source>N Engl J Med</source>.
<year>2003</year>;<volume>348</volume>(<issue>20</issue>):<fpage>1953</fpage>&#x02013;<lpage>1966</lpage>.<pub-id pub-id-type="pmid">12690092</pub-id></mixed-citation></ref><ref id="CIT0003"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peiris</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>LL</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Coronavirus as a possible cause of severe acute respiratory
syndrome</article-title>. <source>Lancet</source>.
<year>2003</year>;<volume>361</volume>(<issue>9366</issue>):<fpage>1319</fpage>&#x02013;<lpage>1325</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(03)13077-2</pub-id><pub-id pub-id-type="pmid">12711465</pub-id></mixed-citation></ref><ref id="CIT0004"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Assiri</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Al-Tawfiq</surname><given-names>JA</given-names></name>,
<name name-style="western"><surname>Al-Rabeeah</surname><given-names>AA</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Epidemiological, demographic, and clinical characteristics of 47 cases of
Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive
study</article-title>. <source>Lancet Infect Dis</source>.
<year>2013</year>;<volume>13</volume>(<issue>9</issue>):<fpage>752</fpage>&#x02013;<lpage>761</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/S1473-3099(13)70204-4</pub-id><pub-id pub-id-type="pmid">23891402</pub-id></mixed-citation></ref><ref id="CIT0005"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drosten</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Seilmaier</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Corman</surname><given-names>VM</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Clinical features and virological analysis of a case of Middle East
respiratory syndrome coronavirus infection</article-title>. <source>Lancet Infect
Dis</source>.
<year>2013</year>;<volume>13</volume>(<issue>9</issue>):<fpage>745</fpage>&#x02013;<lpage>751</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1473-3099(13)70154-3</pub-id><pub-id pub-id-type="pmid">23782859</pub-id></mixed-citation></ref><ref id="CIT0006"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaki</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>van
Boheemen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bestebroer</surname><given-names>TM</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Isolation of a novel coronavirus from a man with pneumonia in Saudi
Arabia</article-title>. <source>N Engl J Med</source>.
<year>2012</year>;<volume>367</volume>(<issue>19</issue>):<fpage>1814</fpage>&#x02013;<lpage>1820</lpage>.<pub-id pub-id-type="pmid">23075143</pub-id></mixed-citation></ref><ref id="CIT0007"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Stratton</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>YW.</given-names></name></person-group>
<article-title>Outbreak of pneumonia of unknown Etiology in Wuhan China: the Mystery and
the Miracle</article-title>. <source>J Med Virol</source>.
<year>2020</year>;<volume>92</volume>(<issue>4</issue>):<fpage>401</fpage>&#x02013;<lpage>402</lpage>.
doi: <pub-id pub-id-type="doi">10.1002/jmv.25678</pub-id><pub-id pub-id-type="pmid">31950516</pub-id></mixed-citation></ref><ref id="CIT0008"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A novel coronavirus from patients with pneumonia in China,
2019</article-title>. <source>N Engl J Med.</source>
<year>2020</year>;<volume>382</volume>(<issue>8</issue>):<fpage>727</fpage>&#x02013;<lpage>733</lpage>.
doi: <pub-id pub-id-type="doi">10.1056/NEJMoa2001017</pub-id><pub-id pub-id-type="pmid">31978945</pub-id></mixed-citation></ref><ref id="CIT0009"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Anonymous</collab></person-group>
<article-title>The species severe acute
respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it
SARS-CoV-2</article-title>. <source>Nat Microbiol</source>. <year>2020</year>. Epub
ahead of print.</mixed-citation></ref><ref id="CIT0010"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Genomic characterisation and epidemiology of 2019 novel coronavirus:
implications for virus origins and receptor binding</article-title>.
<source>Lancet</source>.
<year>2020</year>;<volume>30</volume>(<issue>20</issue>):<fpage>30251</fpage>&#x02013;<lpage>30258</lpage>.</mixed-citation></ref><ref id="CIT0011"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>XG</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A pneumonia outbreak associated with a new coronavirus of probable bat
origin</article-title>. <source>Nature</source>.
<year>2020</year>;<volume>579</volume>(<issue>7798</issue>):<fpage>270</fpage>&#x02013;<lpage>273</lpage>.
doi: <pub-id pub-id-type="doi">10.1038/s41586-020-2012-7</pub-id><pub-id pub-id-type="pmid">32015507</pub-id></mixed-citation></ref><ref id="CIT0012"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaunt</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Hardie</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Claas</surname><given-names>EC</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Epidemiology and clinical presentations of the four human coronaviruses
229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR
method</article-title>. <source>J Clin Microbiol</source>.
<year>2010</year>;<volume>48</volume>(<issue>8</issue>):<fpage>2940</fpage>&#x02013;<lpage>2947</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JCM.00636-10</pub-id><pub-id pub-id-type="pmid">20554810</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <etal>et al.</etal></person-group>
<article-title>MERS, SARS, and Ebola: The role of super-spreaders in infectious
disease</article-title>. <source>Cell Host Microbe</source>.
<year>2015</year>;<volume>18</volume>(<issue>4</issue>):<fpage>398</fpage>&#x02013;<lpage>401</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/j.chom.2015.09.013</pub-id><pub-id pub-id-type="pmid">26468744</pub-id></mixed-citation></ref><ref id="CIT0014"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name>, <name name-style="western"><surname>He</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group>
<article-title>COVID-19: epidemiology, evolution, and cross-disciplinary
perspectives</article-title>. <source>Trends Mol Med</source>. <year>2020</year>. Epub
ahead of print.</mixed-citation></ref><ref id="CIT0015"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>P</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Early transmission dynamics in Wuhan, China, of novel coronavirus-infected
pneumonia</article-title>. <source>N Engl J Med</source>. <year>2020</year>. Epub ahead
of print.</mixed-citation></ref><ref id="CIT0016"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Clinical features of patients infected with 2019 novel coronavirus in
Wuhan, China</article-title>. <source>Lancet</source>.
<year>2020</year>;<volume>24</volume>(<issue>20</issue>):<fpage>30183</fpage>&#x02013;<lpage>30185</lpage>.</mixed-citation></ref><ref id="CIT0017"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>F.</given-names></name></person-group>
<article-title>Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV)
in Wuhan, China</article-title>. <source>J Med Virol</source>.
<year>2020</year>;<volume>92</volume>(<issue>4</issue>):<fpage>441</fpage>&#x02013;<lpage>447</lpage>.
doi: <pub-id pub-id-type="doi">10.1002/jmv.25689</pub-id><pub-id pub-id-type="pmid">31994742</pub-id></mixed-citation></ref><ref id="CIT0018"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Clinical course and outcomes of critically ill patients with SARS-CoV-2
pneumonia in Wuhan, China: a single-centered, retrospective, observational
study</article-title>. <source>Lancet Respir Med</source>. <year>2020</year>. Epub ahead
of print.</mixed-citation></ref><ref id="CIT0019"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Lou</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Characteristics of COVID-19 infection in Beijing</article-title>. <source>J
Infect</source>.
<year>2020</year>;<volume>27</volume>(<issue>20</issue>):<fpage>30101</fpage>&#x02013;<lpage>30108</lpage>.</mixed-citation></ref><ref id="CIT0020"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holshue</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>DeBolt</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lindquist</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group>
<article-title>First case of 2019 novel coronavirus in the United States</article-title>.
<source>N Engl J Med</source>.
<year>2020</year>;<volume>382</volume>(<issue>10</issue>):<fpage>929</fpage>&#x02013;<lpage>936</lpage>.
doi: <pub-id pub-id-type="doi">10.1056/NEJMoa2001191</pub-id><pub-id pub-id-type="pmid">32004427</pub-id></mixed-citation></ref><ref id="CIT0021"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in
children: experts&#x02019; consensus statement</article-title>. <source>World J
Pediatr</source>. <year>2020</year>. Epub ahead of print.</mixed-citation></ref><ref id="CIT0022"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Ni</surname><given-names>ZY</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Clinical characteristics of coronavirus disease 2019 in
China</article-title>. <source>N Engl J Med</source>. <year>2020</year>. Epub ahead of
print.</mixed-citation></ref><ref id="CIT0023"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charlton</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Babady</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ginocchio</surname><given-names>CC</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Practical guidance for clinical microbiology laboratories: viruses causing
acute respiratory tract infections</article-title>. <source>Clin Microbiol Rev</source>.
<year>2019</year>;<volume>32</volume>(<issue>1</issue>). doi: <pub-id pub-id-type="doi">10.1128/CMR.00042-18</pub-id></mixed-citation></ref><ref id="CIT0024"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Falsey</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Formica</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Walsh</surname><given-names>EE.</given-names></name></person-group>
<article-title>Simple method for combining sputum and nasal samples for virus detection by
reverse transcriptase PCR</article-title>. <source>J Clin Microbiol</source>.
<year>2012</year>;<volume>50</volume>(<issue>8</issue>):<fpage>2835</fpage>.
doi: <pub-id pub-id-type="doi">10.1128/JCM.01473-12</pub-id><pub-id pub-id-type="pmid">22692748</pub-id></mixed-citation></ref><ref id="CIT0025"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>R</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Detection of SARS-CoV-2 in different types of clinical
specimens</article-title>. <source>Jama</source>. <year>2020</year>. Epub ahead of
print.</mixed-citation></ref><ref id="CIT0026"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>LK</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Viral shedding patterns of coronavirus in patients with probable severe
acute respiratory syndrome</article-title>. <source>Lancet</source>.
<year>2004</year>;<volume>363</volume>(<issue>9422</issue>):<fpage>1699</fpage>&#x02013;<lpage>1700</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(04)16255-7</pub-id><pub-id pub-id-type="pmid">15158632</pub-id></mixed-citation></ref><ref id="CIT0027"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Abdely</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Midgley</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Alkhamis</surname><given-names>AM</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Middle East respiratory syndrome coronavirus infection dynamics and
antibody Responses among clinically Diverse patients, Saudi Arabia</article-title>.
<source>Emerg Infect Dis</source>.
<year>2019</year>;<volume>25</volume>(<issue>4</issue>):<fpage>753</fpage>&#x02013;<lpage>766</lpage>.<pub-id pub-id-type="pmid">30882305</pub-id></mixed-citation></ref><ref id="CIT0028"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poissy</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Goffard</surname><given-names>A</given-names></name>,
<name name-style="western"><surname>Parmentier-Decrucq</surname><given-names>E</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Kinetics and pattern of viral excretion in biological specimens of two
MERS-CoV cases</article-title>. <source>J Clin Virol</source>.
<year>2014</year>;<volume>61</volume>(<issue>2</issue>):<fpage>275</fpage>&#x02013;<lpage>278</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcv.2014.07.002</pub-id><pub-id pub-id-type="pmid">25073585</pub-id></mixed-citation></ref><ref id="CIT0029"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Persistent shedding of viable SARS-CoV in urine and stool of SARS patients
during the convalescent phase</article-title>. <source>Eur J Clin Microbiol Infect
Dis</source>.
<year>2005</year>;<volume>24</volume>(<issue>3</issue>):<fpage>165</fpage>&#x02013;<lpage>171</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10096-005-1299-5</pub-id><pub-id pub-id-type="pmid">15789222</pub-id></mixed-citation></ref><ref id="CIT0030"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>To</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Tsang</surname><given-names>OT</given-names></name>, <name name-style="western"><surname>Chik-Yan
Yip</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Consistent detection of 2019 novel coronavirus in saliva</article-title>.
<source>Clin Infect Dis</source>. <year>2020</year>. Epub ahead of
print.</mixed-citation></ref><ref id="CIT0031"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamre</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kindig</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Mann</surname><given-names>J.</given-names></name></person-group>
<article-title>Growth and intracellular development of a new respiratory
virus</article-title>. <source>J Virol</source>.
<year>1967</year>;<volume>1</volume>(<issue>4</issue>):<fpage>810</fpage>&#x02013;<lpage>816</lpage>.
doi: <pub-id pub-id-type="doi">10.1128/JVI.1.4.810-816.1967</pub-id><pub-id pub-id-type="pmid">4912236</pub-id></mixed-citation></ref><ref id="CIT0032"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tyrrell</surname><given-names>DAJ</given-names></name>, <name name-style="western"><surname>Bynoe</surname><given-names>ML.</given-names></name></person-group>
<article-title>Cultivation of a novel type of common-cold virus in organ
cultures</article-title>. <source>Br Med J</source>.
<year>1965</year>;<volume>1</volume>(<issue>5448</issue>):<fpage>1467</fpage>&#x02013;<lpage>1470</lpage>.
doi: <pub-id pub-id-type="doi">10.1136/bmj.1.5448.1467</pub-id><pub-id pub-id-type="pmid">14288084</pub-id></mixed-citation></ref><ref id="CIT0033"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A highly specific rapid antigen detection assay for on-site diagnosis of
MERS</article-title>. <source>J Infect</source>.
<year>2016</year>;<volume>73</volume>(<issue>1</issue>):<fpage>82</fpage>&#x02013;<lpage>84</lpage>.
doi:<pub-id pub-id-type="doi">10.1016/j.jinf.2016.1004.1014</pub-id> doi: <pub-id pub-id-type="doi">10.1016/j.jinf.2016.04.014</pub-id><pub-id pub-id-type="pmid">27144915</pub-id></mixed-citation></ref><ref id="CIT0034"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lau</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Woo</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>BH</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Detection of severe acute respiratory syndrome (SARS) coronavirus
nucleocapsid protein in SARS patients by enzyme-linked immunosorbent
assay</article-title>. <source>J Clin Microbiol</source>.
<year>2004</year>;<volume>42</volume>(<issue>7</issue>):<fpage>2884</fpage>&#x02013;<lpage>2889</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JCM.42.7.2884-2889.2004</pub-id><pub-id pub-id-type="pmid">15243033</pub-id></mixed-citation></ref><ref id="CIT0035"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sastre</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Dijkman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Camunas</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Differentiation between human coronaviruses NL63 and 229E using a novel
double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal
antibodies</article-title>. <source>Clin Vaccine Immunol</source>.
<year>2011</year>;<volume>18</volume>(<issue>1</issue>):<fpage>113</fpage>&#x02013;<lpage>118</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CVI.00355-10</pub-id><pub-id pub-id-type="pmid">21084464</pub-id></mixed-citation></ref><ref id="CIT0036"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>IJ</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Yeh</surname><given-names>SH</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Immunofluorescence assay for detection of the nucleocapsid antigen of the
severe acute respiratory syndrome (SARS)-associated coronavirus in cells derived from
throat wash samples of patients with SARS</article-title>. <source>J Clin
Microbiol</source>.
<year>2005</year>;<volume>43</volume>(<issue>5</issue>):<fpage>2444</fpage>&#x02013;<lpage>2448</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JCM.43.5.2444-2448.2005</pub-id><pub-id pub-id-type="pmid">15872279</pub-id></mixed-citation></ref><ref id="CIT0037"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sizun</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Arbour</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Talbot</surname><given-names>PJ.</given-names></name></person-group>
<article-title>Comparison of immunofluorescence with monoclonal antibodies and RT-PCR for
the detection of human coronaviruses 229E and OC43 in cell culture</article-title>.
<source>J Virol Methods</source>.
<year>1998</year>;<volume>72</volume>(<issue>2</issue>):<fpage>145</fpage>&#x02013;<lpage>152</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0166-0934(98)00013-5</pub-id><pub-id pub-id-type="pmid">9694322</pub-id></mixed-citation></ref><ref id="CIT0038"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Evaluation of a commercial colloidal gold assay for detection of influenza
A and B virus in children's respiratory specimens</article-title>. <source>Fetal Pediatr
Pathol</source>.
<year>2019</year>;<volume>15</volume>:<fpage>1</fpage>&#x02013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15513815.2019.1639088</pub-id></mixed-citation></ref><ref id="CIT0039"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruning</surname><given-names>AHL</given-names></name>, <name name-style="western"><surname>Aatola</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Toivola</surname><given-names>H</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Rapid detection and monitoring of human coronavirus
infections</article-title>. <source>New Microbes New Infect</source>.
<year>2018</year>;<volume>24</volume>:<fpage>52</fpage>&#x02013;<lpage>55</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nmni.2018.1004.1007</pub-id> doi: <pub-id pub-id-type="doi">10.1016/j.nmni.2018.04.007</pub-id><pub-id pub-id-type="pmid">29872531</pub-id></mixed-citation></ref><ref id="CIT0040"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Tse</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>SS</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Examination of seroprevalence of coronavirus HKU1 infection with S
protein-based ELISA and neutralization assay against viral spike pseudotyped
virus</article-title>. <source>J Clin Virol</source>.
<year>2009</year>;<volume>45</volume>(<issue>1</issue>):<fpage>54</fpage>&#x02013;<lpage>60</lpage>.
doi:<pub-id pub-id-type="doi">10.1016/j.jcv.2009.1002.1011</pub-id> doi: <pub-id pub-id-type="doi">10.1016/j.jcv.2009.02.011</pub-id><pub-id pub-id-type="pmid">19342289</pub-id></mixed-citation></ref><ref id="CIT0041"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Esper</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Seroepidemiology of group I human coronaviruses in
children</article-title>. <source>J Clin Virol</source>.
<year>2007</year>;<volume>40</volume>(<issue>3</issue>):<fpage>207</fpage>&#x02013;<lpage>213</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcv.2007.08.007</pub-id><pub-id pub-id-type="pmid">17889596</pub-id></mixed-citation></ref><ref id="CIT0042"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>B</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Molecular and serological investigation of 2019-nCoV infected patients:
implication of multiple shedding routes</article-title>. <source>Emerg Microbes
Infect</source>.
<year>2020</year>;<volume>9</volume>(<issue>1</issue>):<fpage>386</fpage>&#x02013;<lpage>389</lpage>. doi: <pub-id pub-id-type="doi">10.1080/22221751.2020.1729071</pub-id><pub-id pub-id-type="pmid">32065057</pub-id></mixed-citation></ref><ref id="CIT0043"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Briese</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mishra</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Middle East respiratory syndrome coronavirus quasispecies that include
homologues of human isolates revealed through whole-genome analysis and virus cultured
from dromedary camels in Saudi Arabia</article-title>. <source>mBio</source>.
<year>2014</year>;<volume>5</volume>(<issue>3</issue>):<fpage>e01146</fpage>&#x02013;<lpage>e01114</lpage>. doi: <pub-id pub-id-type="doi">10.1128/mBio.01146-14</pub-id><pub-id pub-id-type="pmid">24781747</pub-id></mixed-citation></ref><ref id="CIT0044"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name>, <etal>et al.</etal></person-group>
<article-title>RNA based mNGS approach identifies a novel human coronavirus from two
individual pneumonia cases in 2019 Wuhan outbreak</article-title>. <source>Emerg
Microbes Infect</source>.
<year>2020</year>;<volume>9</volume>(<issue>1</issue>):<fpage>313</fpage>&#x02013;<lpage>319</lpage>. doi: <pub-id pub-id-type="doi">10.1080/22221751.2020.1725399</pub-id><pub-id pub-id-type="pmid">32020836</pub-id></mixed-citation></ref><ref id="CIT0045"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>B</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A new coronavirus associated with human respiratory disease in
China</article-title>. <source>Nature</source>.
<year>2020</year>;<volume>579</volume>(<issue>7798</issue>):<fpage>265</fpage>&#x02013;<lpage>269</lpage>.
doi: <pub-id pub-id-type="doi">10.1038/s41586-020-2008-3</pub-id><pub-id pub-id-type="pmid">32015508</pub-id></mixed-citation></ref><ref id="CIT0046"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>ZQ</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Identification of a novel coronavirus causing severe pneumonia in human: a
descriptive study</article-title>. <source>Chin Med J</source>. <year>2020</year>. Epub
ahead of print.</mixed-citation></ref><ref id="CIT0047"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>X</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Co-infection with SARS-CoV-2 and influenza A virus in patient with
pneumonia, China</article-title>. <source>Emerg Infect Dis</source>.
<year>2020</year>;<volume>26</volume>(<issue>6</issue>). doi: <pub-id pub-id-type="doi">10.3201/eid2606.200299</pub-id></mixed-citation></ref><ref id="CIT0048"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Das</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dunbar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>YW.</given-names></name></person-group>
<article-title>Laboratory diagnosis of respiratory tract infections in children - the
State of the Art</article-title>. <source>Front Microbiol</source>.
<year>2018</year>;<volume>9</volume>:<fpage>2478</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2018.02478</pub-id>.<pub-id pub-id-type="pmid">30405553</pub-id></mixed-citation></ref><ref id="CIT0049"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahony</surname><given-names>JB</given-names></name>,
<name name-style="western"><surname>Richardson</surname><given-names>S.</given-names></name></person-group>
<article-title>Molecular diagnosis of severe acute respiratory syndrome: the state of the
art</article-title>. <source>J Mol Diagn</source>.
<year>2005</year>;<volume>7</volume>(<issue>5</issue>):<fpage>551</fpage>&#x02013;<lpage>559</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1525-1578(10)60587-9</pub-id><pub-id pub-id-type="pmid">16258152</pub-id></mixed-citation></ref><ref id="CIT0050"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>YW.</given-names></name></person-group>
<article-title>Emerging molecular assays for detection and characterization of respiratory
viruses</article-title>. <source>Clin Lab Med</source>.
<year>2009</year>;<volume>29</volume>(<issue>4</issue>):<fpage>673</fpage>&#x02013;<lpage>693</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cll.2009.07.005</pub-id><pub-id pub-id-type="pmid">19892228</pub-id></mixed-citation></ref><ref id="CIT0051"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>YW.</given-names></name></person-group>
<article-title>Molecular assays for the detection and characterization of respiratory
viruses</article-title>. <source>Semin Respir Crit Care Med</source>.
<year>2011</year>;<volume>32</volume>(<issue>4</issue>):<fpage>512</fpage>&#x02013;<lpage>526</lpage>.<pub-id pub-id-type="pmid">21858753</pub-id></mixed-citation></ref><ref id="CIT0052"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zlateva</surname><given-names>KT</given-names></name>,
<name name-style="western"><surname>Coenjaerts</surname><given-names>FE</given-names></name>, <name name-style="western"><surname>Crusio</surname><given-names>KM</given-names></name>, <etal>et al.</etal></person-group>
<article-title>No novel coronaviruses identified in a large collection of human
nasopharyngeal specimens using family-wide CODEHOP-based primers</article-title>.
<source>Arch Virol</source>.
<year>2013</year>;<volume>158</volume>(<issue>1</issue>):<fpage>251</fpage>&#x02013;<lpage>255</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00705-012-1487-4</pub-id><pub-id pub-id-type="pmid">23053517</pub-id></mixed-citation></ref><ref id="CIT0053"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuypers</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Heugel</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Clinical disease in children associated with newly described coronavirus
subtypes</article-title>. <source>Pediatrics</source>.
<year>2007</year>;<volume>119</volume>(<issue>1</issue>):<fpage>e70</fpage>&#x02013;<lpage>e76</lpage>.
doi:<pub-id pub-id-type="doi">10.1542/peds.2006-1406</pub-id>.<pub-id pub-id-type="pmid">17130280</pub-id></mixed-citation></ref><ref id="CIT0054"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woo</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>CM</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Characterization and complete genome sequence of a novel coronavirus,
coronavirus HKU1, from patients with pneumonia</article-title>. <source>J
Virol</source>.
<year>2005</year>;<volume>79</volume>(<issue>2</issue>):<fpage>884</fpage>&#x02013;<lpage>895</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JVI.79.2.884-895.2005</pub-id><pub-id pub-id-type="pmid">15613317</pub-id></mixed-citation></ref><ref id="CIT0055"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babady</surname><given-names>NE</given-names></name>, <name name-style="western"><surname>England</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Jurcic
Smith</surname><given-names>KL</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Multicenter evaluation of the ePlex respiratory pathogen panel for the
detection of viral and bacterial respiratory tract pathogens in nasopharyngeal
swabs</article-title>. <source>J Clin Microbiol</source>.
<year>2018</year>;<volume>56</volume>(<issue>2</issue>). doi: <pub-id pub-id-type="doi">10.1128/JCM.01658-17</pub-id></mixed-citation></ref><ref id="CIT0056"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babady</surname><given-names>NE</given-names></name>, <name name-style="western"><surname>Mead</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Stiles</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Comparison of the Luminex xTAG RVP fast assay and the Idaho Technology
FilmArray RP assay for detection of respiratory viruses in pediatric patients at a
cancer hospital</article-title>. <source>J Clin Microbiol</source>.
<year>2012</year>;<volume>50</volume>(<issue>7</issue>):<fpage>2282</fpage>&#x02013;<lpage>2288</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JCM.06186-11</pub-id><pub-id pub-id-type="pmid">22518855</pub-id></mixed-citation></ref><ref id="CIT0057"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>YW</given-names></name>, <name name-style="western"><surname>Gonsalves</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>JY</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Clinical evaluation of the Luminex NxTAG respiratory pathogen
panel</article-title>. <source>J Clin Microbiol</source>.
<year>2016</year>;<volume>54</volume>(<issue>7</issue>):<fpage>1912</fpage>&#x02013;<lpage>1914</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JCM.00482-16</pub-id><pub-id pub-id-type="pmid">27122378</pub-id></mixed-citation></ref><ref id="CIT0058"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases
from one hospital in Wuhan, China, from Jan to Feb 2020</article-title>. <source>Clin
Chim Acta</source>. <year>2020</year>. Epub ahead of print.</mixed-citation></ref><ref id="CIT0059"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rothe</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Schunk</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sothmann</surname><given-names>P</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Transmission of 2019-nCoV infection from an asymptomatic contact in
Germany</article-title>. <source>N Engl J Med</source>.
<year>2020</year>;<volume>382</volume>(<issue>10</issue>):<fpage>970</fpage>&#x02013;<lpage>971</lpage>.
doi: <pub-id pub-id-type="doi">10.1056/NEJMc2001468</pub-id><pub-id pub-id-type="pmid">32003551</pub-id></mixed-citation></ref><ref id="CIT0060"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corman</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Landt</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Kaiser</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Detection of 2019 novel coronavirus (2019-nCoV) by real-time
RT-PCR</article-title>. <source>Euro Surveill</source>.
<year>2020</year>;<volume>25</volume>(<issue>3</issue>). doi:<pub-id pub-id-type="doi">10.2807/1560-7917.ES.2020.2825.2803.2000045</pub-id> doi: <pub-id pub-id-type="doi">10.2807/1560-7917.ES.2020.25.3.2000045</pub-id></mixed-citation></ref><ref id="CIT0061"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Kok</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Z</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Genomic characterization of the 2019 novel human-pathogenic coronavirus
isolated from a patient with atypical pneumonia after visiting Wuhan</article-title>.
<source>Emerg Microbes Infect</source>.
<year>2020</year>;<volume>9</volume>(<issue>1</issue>):<fpage>221</fpage>&#x02013;<lpage>236</lpage>. doi: <pub-id pub-id-type="doi">10.1080/22221751.2020.1719902</pub-id><pub-id pub-id-type="pmid">31987001</pub-id></mixed-citation></ref><ref id="CIT0062"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raftery</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Condell</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Wasunna</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Establishing Ebola virus disease (EVD) diagnostics using GeneXpert
technology at a mobile laboratory in Liberia: impact on outbreak response, case
management and laboratory systems strengthening</article-title>. <source>PLoS Negl Trop
Dis</source>.
<year>2018</year>;<volume>12</volume>(<issue>1</issue>):<fpage>e0006135</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0006135</pub-id><pub-id pub-id-type="pmid">29304039</pub-id></mixed-citation></ref><ref id="CIT0063"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kozel</surname><given-names>TR</given-names></name>,
<name name-style="western"><surname>Burnham-Marusich</surname><given-names>AR.</given-names></name></person-group>
<article-title>Point-of-care testing for infectious diseases: past, present, and
future</article-title>. <source>J Clin Microbiol</source>.
<year>2017</year>;<volume>55</volume>(<issue>8</issue>):<fpage>2313</fpage>&#x02013;<lpage>2320</lpage>.doi: <pub-id pub-id-type="doi">10.1128/JCM.00476-17</pub-id><pub-id pub-id-type="pmid">28539345</pub-id></mixed-citation></ref><ref id="CIT0064"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nie</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Roth</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Stiles</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Evaluation of Alere i influenza A&#x00026;B for rapid detection of influenza
viruses A and B</article-title>. <source>J Clin Microbiol</source>.
<year>2014</year>;<volume>52</volume>(<issue>9</issue>):<fpage>3339</fpage>&#x02013;<lpage>3344</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JCM.01132-14</pub-id><pub-id pub-id-type="pmid">24989611</pub-id></mixed-citation></ref><ref id="CIT0065"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>YW.</given-names></name></person-group>
<article-title>Profile of the Alere i influenza A &#x00026; B assay: a pioneering molecular
point-of-care test</article-title>. <source>Expert Rev Mol Diagn</source>.
<year>2018</year>;<volume>18</volume>(<issue>5</issue>):<fpage>403</fpage>&#x02013;<lpage>409</lpage>. doi: <pub-id pub-id-type="doi">10.1080/14737159.2018.1466703</pub-id><pub-id pub-id-type="pmid">29688086</pub-id></mixed-citation></ref><ref id="CIT0066"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ling</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kaplan</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>JC</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Parallel validation of three molecular devices for simultaneous detection
and identification of influenza A and B and respiratory syncytial
viruses</article-title>. <source>J Clin Microbiol</source>.
<year>2018</year>;<volume>56</volume>(<issue>3</issue>). doi: <pub-id pub-id-type="doi">10.1128/JCM.01691-17</pub-id></mixed-citation></ref><ref id="CIT0067"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beal</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Posa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gaffar</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Performance and impact of a CLIA-waived, point-of-care respiratory PCR
Panel in a pediatric clinic</article-title>. <source>Pediatr Infect Dis J</source>.
<year>2020</year>;<volume>39</volume>(<issue>3</issue>):<fpage>188</fpage>&#x02013;<lpage>191</lpage>.<pub-id pub-id-type="pmid">31929382</pub-id></mixed-citation></ref><ref id="CIT0068"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Hoek</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pyrc</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Jebbink</surname><given-names>MF</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Identification of a new human coronavirus</article-title>. <source>Nat
Med</source>.
<year>2004</year>;<volume>10</volume>(<issue>4</issue>):<fpage>368</fpage>&#x02013;<lpage>373</lpage>.<pub-id pub-id-type="pmid">15034574</pub-id></mixed-citation></ref><ref id="CIT0069"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Tsang</surname><given-names>AK</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Development and evaluation of novel real-time reverse transcription-PCR
assays with Locked nucleic acid probes targeting leader sequences of human-pathogenic
coronaviruses</article-title>. <source>J Clin Microbiol</source>.
<year>2015</year>;<volume>53</volume>(<issue>8</issue>):<fpage>2722</fpage>&#x02013;<lpage>2726</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JCM.01224-15</pub-id><pub-id pub-id-type="pmid">26019210</pub-id></mixed-citation></ref><ref id="CIT0070"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dare</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Fry</surname><given-names>AM</given-names></name>,
<name name-style="western"><surname>Chittaganpitch</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Human coronavirus infections in rural Thailand: a comprehensive study using
real-time reverse-transcription polymerase chain reaction assays</article-title>.
<source>J Infect Dis</source>.
<year>2007</year>;<volume>196</volume>(<issue>9</issue>):<fpage>1321</fpage>&#x02013;<lpage>1328</lpage>.<pub-id pub-id-type="pmid">17922396</pub-id></mixed-citation></ref></ref-list></back></article>